Fourth Quarter and Full Year Fiscal 2016 Financial Results ...s2.q4cdn.com/797845863/files/doc_presentations/... · Fourth Quarter and Full Year Fiscal 2016 Financial Results –Supplemental

Fourth Quarter and Full Year Fiscal 2016

Financial Results – Supplemental Materials

March 16, 2016

Forward-looking Statements

Information included in this presentation may contain forward-looking statements within

the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking

statements are not statements of historical fact, but rather reflect our current expectations

concerning future events and results. These statements may include the use of the words

“believes,” “expects,” “intends,” “plans,” “anticipates,” “likely,” “continues,” “may,” “will,”

and similar expressions to identify forward-looking statements. Such forward-looking

statements, including those concerning growth through acquisitions, involve risks,

uncertainties and other factors, some of which are beyond our control, which may cause

our actual results, performance or achievements to be materially different from those

expressed or implied by such forward-looking statements. These risks, uncertainties, and

factors include, but are not limited to, those factors set forth in the Company’s Annual

Report on Form 10-K for the fiscal year ended January 31, 2015 and subsequent filings

Astro-Med makes with the Securities and Exchange Commission. The Company

undertakes no obligation to publicly update or revise any forward-looking statements,

whether as a result of new information, future events or otherwise. The reader is

cautioned not to unduly rely on such forward-looking statements when evaluating the

information presented in this presentation.

Q4 and FY 2016 Financial Results

Supplemental Materials 2©2016 Astro-Med, Inc. d/b/a AstroNova All rights reserved. |

Use of Non-GAAP Financial Measures

In addition to financial measures prepared in accordance with generally accepted

accounting principles (GAAP), this presentation contains the following non-GAAP

financial measures: non-GAAP net income per diluted share and free cash flow. The

Company believes that the inclusion of these non-GAAP financial measures in this

presentation helps investors to gain a meaningful understanding of changes in the

Company's core operating results, and also can help investors who wish to make

comparisons between AstroNova and other companies on both a GAAP and a non-GAAP

basis. AstroNova’s management uses these non-GAAP measures, in addition to GAAP

financial measures, as the basis for measuring its core operating performance and

comparing such performance to that of prior periods and to the performance of its

competitors. These measures are also used by the Company’s management to assist

with their financial and operating decision-making. Please see the reconciliation table on

Slide 14 for a reconciliation of the non-GAAP financial measures to the most directly

comparable GAAP measures.



Q4 Fiscal 2016 Performance Summary



$20.8

$24.9

Q4 FY15 Q4 FY16

Bookings

+ 19.7%

$22.1

$23.8

Q4 FY15 Q4 FY16

Revenue

+ 7.7%

($ in millions)

Q4 Fiscal 2016 Performance Summary



$0.10

$0.17

Q4 FY15 Q4 FY16

Non-GAAP EPS

+ 70.0%

$0.07

$0.11

Q4 FY15 Q4 FY16

GAAP EPS

+ 57.1%

Full Year Fiscal 2016 Performance Summary



(Text)

$88.3

$102.3

FY15 FY16

Bookings

+ 15.9%

Record

$88.3

$94.7

FY15 FY16

Revenue

+ 7.1%

Record

($ in millions)

Full Year Fiscal 2016 Performance Summary



(Text)

$0.65

$0.77

FY15 FY16

Non-GAAP EPS

+ 18.5%

$.60

$0.61

FY15 FY16

GAAP EPS

+ 1.7%

Free Cash Flow

12 Months Ended

January 31, 2015

12 Months Ended

January 31, 2016

Net Cash Provided by

Operating Activities

$1,491 $7,727

Capital Expenditures ($2,247) ($3,061)

Free Cash Flow ($756) $4,666


Supplemental Materials©2016 Astro-Med, Inc. d/b/a AstroNova All rights reserved. | 8

($ in Thousands)

QuickLabel Systems Q4 Fiscal 2016 Performance



$14.5

$16.2

Q4 FY15 Q4 FY16

Bookings

+ 11.6%

$14.8

$16.6

Q4 FY15 Q4 FY16

Revenue

+ 12.1%

$0.9

$1.7

Q4 FY15 Q4 FY16

Operating Profit

+ 88.9%

($ in millions)

QuickLabel Systems FY Fiscal 2016 Performance



$60.3

$69.3

FY15 FY16

Bookings

+ 15.0%

$59.8

$67.1

FY15 FY16

Revenue

+ 12.3%

$7.3

$9.3

FY15 FY16

Operating Profit

+ 29.2%

($ in millions)

Test & Measurement Q4 Fiscal 2016 Performance



$6.3

$8.8

Q4 FY15 Q4 FY16

Bookings

+ 38.2%

$7.2

$7.1

Q4 FY15 Q4 FY16

Revenue

(1.4%)

$1.6

$1.0

Q4 FY15 Q4 FY16

Operating Profit

(37.5%)

($ in millions)

Test & Measurement FY Fiscal 2016 Performance



$28.0

$32.9

FY15 FY16

Bookings

+ 17.5%

$28.6

$27.5

FY15 FY16

Revenue

(3.6%)

$5.6

$3.7

FY15 FY16

Operating Profit

(33.9%)

($ in millions)

Thank You!


Supplemental Materials13©2016 Astro-Med, Inc. d/b/a AstroNova All rights reserved. |

Reconciliation of Non-GAAP EPS

GAAP based results:EPS-Diluted $0.11 $0.07 $0.61 $0.60

Add Back - Non-GAAP adjustments (net of taxes):

Rebranding Initiatives 0.02 - 0.02 -

RITEC Transaction/Transition Costs 0.03 - 0.09 -

2016 Long-Term Incentive Plan Share-Based Compensation 0.01 - 0.05 -

Write-down of TSA Inventory - - - 0.02

Share Buyback Costs - 0.01 - 0.01

Write-down of Asset Held for Sale - 0.02 - 0.02Non-GAAP EPS - Diluted $0.17 $0.10 $0.77 $0.65

14

Three –Months EndedJanuary 31, 2016 January 31, 2015

Twelve –Months EndedJanuary 31, 2016 January 31, 2015


Supplemental Materials©2016 Astro-Med, Inc. d/b/a AstroNova All rights reserved. |

Documents

Fourth Quarter and Full Year Fiscal 2016 Financial Results ...s2.q4cdn.com/797845863/files/doc_presentations/... · Fourth Quarter and Full Year Fiscal 2016 Financial Results –Supplemental